510(k) K880617
K880617 is an FDA 510(k) premarket notification submitted by Pasco Laboratories, Inc. for the device "ADDITION OF AMPICILLIN/SULBACTAM & CIPROFLOXACIN". The FDA issued a decision of Substantially Equivalent on Mar 16, 1988. The device falls under product code JWY (Manual Antimicrobial Susceptibility Test Systems), a Class II device regulated under 21 CFR 866.1640. Pasco Laboratories, Inc. has 65 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 16, 1988
- Date Received
- Feb 16, 1988
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Manual Antimicrobial Susceptibility Test Systems
- Device Class
- Class II
- Regulation Number
- 866.1640
- Review Panel
- MI
- Submission Type
- 510(k)